Ganitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.